Ester Ballana

[EurekAlert! @EurekAlert]

#EurekAlertInTheSpotlight: A new study has found that a group of genes could anticipate the response to a key breast cancer treatment. @GTRecerca #BreastCancerAwarenessMonth🎗️🩷 Learn more here: https://t.co/qtx6gu2rw0

[IrsiCaixa @IrsiCaixa]

🧬 New finding: KIMA, a group of 9 genes that shows which HR+/HER2– breast cancer patients may respond better or worse to treatment with CDK4/6 inhibitors.

🔬 Knowing this before treatment can help tailor therapy more effectively for each patient.

https://t.co/AKhG6GBgba

[Institut Català d'Oncologia @ICO_oncologia]

Un grup de gens pot predir la resposta al tractament clau contra el #càncer de #mama HR+/HER2–
🔬 La signatura genòmica #KIMA identifica les pacients amb pitjor resposta als inhibidors de CDK4/6 i obre la porta a teràpies més personalitzades
➡️https://t.co/PCDPgqEAqX

[IGTP @GTRecerca]

🔵 Un equip d'@IrsiCaixa, @ICO_oncologia i IGTP identifica KIMA, una signatura genòmica que anticipa la resposta als inhibidors de CDK4/6 en càncer de mama HR+/HER2-

🎯 Una eina per decisions clíniques més precises i tractaments personalitzats

ℹ️ https://t.co/XaBJfB1Mrb

[IGTP @GTRecerca]

🔵 A team from @IrsiCaixa, @ICO_oncologia and IGTP has identified KIMA, a genomic signature anticipating response to CDK4/6 inhibitors in HR+/HER2- breast cancer

🎯 A tool to support more precise decisions and personalised treatments

ℹ️ https://t.co/ATMmZjpLee

[IrsiCaixa @IrsiCaixa]

🧬 Nova troballa: KIMA, un grup de 9 gens que mostra quines pacients amb càncer de mama HR+/HER2– respondrien millor o pitjor al tractament amb inhibidors de CDK4/6.

🔬 Saber-ho abans del tractament pot ajudar a adaptar millor la teràpia a cada pacient.

https://t.co/85aqYBNQgh

[IGTP @GTRecerca]

🆕 @fundacionmutua funds the ERICA Project to study the role of unknown viruses in head and neck tumours

🤝🏼 A collaboration between the teams of Beatriz Cirauqui and @eballana at IGTP, @ICO_oncologia and @IrsiCaixa

Read more: https://t.co/GQRBRwA6BL

[IrsiCaixa @IrsiCaixa]

🎉 Avui, la investigadora d'#IrsiCaixa, Edurne Garcia-Vidal, rep la subvenció de Recerca Jove i Emergent de @bcn_ajuntament!

💡 Aquesta beca se centra en l'esquistosomiasi, una infecció negligida que afecta a més de 250 milions de persones.

Enhorabona, Edurne! 🚀🔬

[IGTP @GTRecerca]

📢 D'aquí un mes tindrà lloc el vuitè Curs B·ARGO d'Immunoteràpia

📌 Despertant el sistema immune: la nova era en la lluita contra el càncer

Més informació i inscripcions: https://t.co/fhCU7d9LG1

[IrsiCaixa @IrsiCaixa]

🤓 IrsiCaixa researchers attended the European Society for Medical Oncology Congress #ESMO24, where the VITI group presented their latest findings on bladder cancer, and the ViHIT group on breast cancer.

🔝 Proud to have such strong representation at this key event!

[IGTP @GTRecerca]

🆕 A new biomarker shows potential for evaluating treatment response in metastatic colorectal cancer

🔬Collaborating through the #CARE and @ProcureICO programmes of IGTP and @ICO_oncologia respectively, researchers identify the protein CXCL13 as an indicator of positive response to oxaliplatin chemotherapy

🗞️ Biomedicine & Pharmacotherapy
https://t.co/gmaQi9UZA9

[IrsiCaixa @IrsiCaixa]

🆕 New paper from the IrsiCaixa ViHIT group is published at @MDPIOpenAccess!

📰 'Nucleotide-Binding Oligomerization Domain 1 Agonists Prevent SARS-CoV-2 Infection in Human Lung Cells via the Innate Immune Response'

👏 Congrats team!

➡️ https://t.co/20WUS8fe0J

[Bea @beatrzirauqui]

@OlivaM_Onc @ICO_oncologia @hgermanstrias @ttccgroup @IrsiCaixa @GTRecerca Gracias @eballana, Eva Riveira, Anna Martínez Cardús, Angelica Ferrando, @Ricard03997694 y a todos los miembros de la Unidad Funcional de Cabeza y Cuello por hacerlo posible

[Ifeanyi Ezeonwumelu, PhD @EzeonwumeluIfea]

Attending the CROI 2024 conference was a much-needed morale boost for me as I continue to advance HIV cure strategies. The opportunity to present my work, receive constructive feedback, and forge new connections left me feeling energized and inspired🌟🤗. #CROI2024Denver #HIVcure

[PPCCSalud @PpccSalud]

🔬 👩‍🔬💊🧬11 mujeres del #PlanComplementario #Biotecnología participaron en el evento #100tifiques (@fundaciorecerca, @_BIST), para celebrar el #11F y acercar la #ciencia a + de 630 estudiantes! #díamujeryniñaenciencia #WomenInSTEM
Más detalles aquí 👇
https://t.co/PEGQtaF1KL

[IrsiCaixa @IrsiCaixa]

👩🏽‍🔬 Les investigadores d'#IrsiCaixa Ester Ballana, Sara Cabrero i Sara Morón han visitat, pel #DiaDonaiNenaCiència, l'@EscolaVirolai i l'Escola La Torreta.

👏🏽 Han compartit amb l'alumnat la seva experiència com a #100tifiques, sent font d'inspiració per les noves generacions.

[IrsiCaixa @IrsiCaixa]

👩🏽‍🔬 Principal investigator Nuria Izquierdo-Useros stresses the critical value of talent retention.

#February11 #WomenInScienceDay

[IrsiCaixa @IrsiCaixa]

👩🏽‍🔬 Principal investigator Ester Ballana highlights the significance of promoting collaboration.

#February11 #WomenInScienceDay

[IrsiCaixa @IrsiCaixa]

👩🏽‍🔬 Principal Investigator Julia Garcia-Prado emphasizes that women's leadership plays a pivotal role in fostering innovative solutions.

#February11 #WomenInScienceDay

[IrsiCaixa @IrsiCaixa]

👩🏽‍🔬 Principal investigator Marta Massanella underscores the importance of placing creativity, empathy, and trust at the forefront.

#February11 #WomenInScienceDay